Quantcast
Channel: Europe Headlines on One News Page [United Kingdom]
Viewing all 65275 articles
Browse latest View live

Global Functional Food Ingredients Market 2018-2022: Market will Register a CAGR of Close to 7% - Increased Demand for Functional Food Ingredients from Probiotics

$
0
0
Dublin, Jan. 22, 2019 (GLOBE NEWSWIRE) -- The "Global Functional Food Ingredients Market 2018-2022" report has been added to *ResearchAndMarkets.com's* offering.

The functional food ingredients market will register a CAGR of close to 7% by 2022.

Growth of packaged food and beverage industry is expected to drive growth in the market. The growth in disposable income and change in food habits has led to a high requirement for packaged food products, particularly in North America and Europe. The demand for packaged product is mainly driven by increased and health and hygiene concerns.

*Market Overview*

*Increased demand for functional food ingredients from probiotics segment*

The probiotics segment of the global functional food ingredients market is gaining traction as customers prefer a more balanced diet that can not only take care of their appetite but also offer nutritional benefits.

*Functional foods and beverages with high sugar*

Functional foods and beverages with high sugar content act as a major challenge for the growth of the functional food ingredients market. The reason being the excessive consumption of these food can lead to high incidences of sugar and obesity.

*Competitive Landscape*

The market appears to be fragmented and with the presence of several companies including BASF and Cargill, the competitive environment is quite intense. Factors such as the growth of packaged food and beverage industry and the increased demand for functional food ingredients from probiotics segment, will provide considerable growth opportunities to functional food ingredients manufacturers.

BASF, Cargill, Chr. Hansen Holding, DowDuPont, DSM, and Naturex are some of the major companies covered in this report.

*Key Topics Covered:*

*PART 01: EXECUTIVE SUMMARY *

*PART 02: SCOPE OF THE REPORT *

*PART 03: RESEARCH METHODOLOGY *

*PART 04: MARKET LANDSCAPE *

· Market ecosystem
· Market characteristics
· Market segmentation analysis

*PART 05: MARKET SIZING *

· Market definition
· Market sizing 2017
· Market size and forecast 2017-2022

*PART 06: FIVE FORCES ANALYSIS *

· Bargaining power of buyers
· Bargaining power of suppliers
· Threat of new entrants
· Threat of substitutes
· Threat of rivalry
· Market condition

*PART 07: MARKET SEGMENTATION BY PRODUCT *· Comparison by product
· Probiotics and prebiotics
· Proteins and amino acid

· Dietary fibers
· Vitamins and minerals
· Omega-3 fatty acids

· Others
· Market opportunity by product

*PART 08: CUSTOMER LANDSCAPE *

*PART 09: REGIONAL LANDSCAPE *

· Geographical segmentation
· Regional comparison
· Key leading countries
· Market opportunity

*PART 10: DECISION FRAMEWORK *

*PART 11: DRIVERS AND CHALLENGES

**PART 12: MARKET TRENDS *

· Growth of packaged food and beverage industry
· Alternate sources for omega-3 fatty acids
· Strategic initiatives undertaken by leading vendors

*PART 13: VENDOR LANDSCAPE *· Landscape disruption
· Competitive Landscape
· Key vendors in global functional food ingredients market

*PART 14: VENDOR ANALYSIS *

· Vendors covered
· Vendor classification
· Market positioning of vendors
· BASF
· Cargill
· Chr. Hansen Holding
· DowDuPont
· DSM
· NaturexFor more information about this report visit https://www.researchandmarkets.com/research/58nrnd/global_functional?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Health Food and Sports Nutrition, Food Ingredients Reported by GlobeNewswire 21 minutes ago.

Gas Pipeline Infrastructure Market worth over $1.5 trillion by 2025: Global Market Insights, Inc.

$
0
0
The U.S. gas pipeline infrastructure market is projected to achieve 4% CAGR from 2019 to 2025 owing to rapid increase in gas connected users along with ongoing up-gradation of unreliable conduit.

Sellbyville, Delaware, Jan. 22, 2019 (GLOBE NEWSWIRE) --Distribution gas pipeline infrastructure market achieve healthy a growth on account of replacement of existing infrastructure in order to comply with the prevailing norms and standards and to improve the supply reliability. Respective government authorities are making significant efforts to boost the domestic gas production and enhance the accessibility of gas across residential and commercial establishments. Government backed network expansion in order to increase gas production from newly developed fields will further lead to the deployment of various large and small diameter pipelines.

Global Gas Pipeline Infrastructure Market is poised to hit USD 1.5 trillion by 2025, as reported in the latest study by Global Market Insights, Inc. Growing production and accessibility from offshore gas fields on account of technological advancements will drive the gas pipeline infrastructure market. Ongoing initiatives to improve the inadequate gas transmission and distribution infrastructure in order to facilitate the cross border and domestic trade will stimulate the industry outlook. Lack of interstate gas pipeline network along with growing dependency on imported natural gas will complement the industry landscape.

The gas pipeline infrastructure market will witness a robust growth on account of increasing demand for clean energy primarily across residential and commercial sector. Rapid industrialization along with shifting trends from coal to gas will propel the business growth. Gradual adoption of natural gas primarily across the chemical, power generation and manufacturing plants will augment the business landscape. In addition, stringent regulations along with ongoing measures to tackle the global climate change will further enhance the industry outlook.

*Request for a sample of this research report @ *https://www.gminsights.com/request-sample/detail/2062

The U.S. market is predicted to grow on account of growing government spending on additional pipeline infrastructure. Increasing rig count with rapidly expanding exploration and production activities will further instigate the requirement of more pipeline assets. New project development across the North East U.S. and Permian basin along with substantial production from shale plays will further support the industry growth.

Prevailing geopolitical scenario along with government concern to maintain the supply security will drive the Europe gas pipeline infrastructure market. Dependency on imported natural gas to meet the energy needs along with predominant diversification plans will require additional transmission pipelines. In addition, environment opposition, anti-pipeline sentiments along with opposition from the local activist groups will impact the clearance of new pipeline projects.

Browse key industry insights spread across 350 pages with 506 market data tables & 11 figures & charts from the report*, “Gas Pipeline Infrastructure Market” i*n detail along with the table of contents:

https://www.gminsights.com/industry-analysis/gas-pipeline-infrastructure-market

Increasing investment towards oil & gas production and development projects on account of volatile hydrocarbon prices will foster the offshore gas pipeline infrastructure market. Globalization along with development of flexible trade policies across various countries will facilitate the investment toward unexplored potential gas fields. As per Rystad Energy, over 100 offshore gas projects are expected to be sanctioned in 2018-19 as compared to 60 in 2017.

 Key participants operating across the gas pipeline infrastructure industry include Europipe, Gazprom, Enbridge, GAIL, APA Group, Chelpipe, Snam Rete, CRC Evans Pipeline, Redexis, General Electric, Technip, Perusahaan Gas Negara, MRC Global, Saipem, DCP Midstream, National Oilwell Varco, Engas and Welspun.

*Make an inquiry for purchasing this report @* https://www.gminsights.com/inquiry-before-buying/2062

*Browse Related Reports:*

· *District Heating Pipeline Network Market Size Forecast 2017 – 2024*

District Heating Pipeline Network Market size in 2016 was valued over USD 400 billion and the cumulative installation is set to exceed 850 thousand Km by 2024 owing to increasing government measures pertaining to carbon emissions coupled with ongoing adoption of heating systems.

https://www.gminsights.com/industry-analysis/district-heating-pipeline-network-market

· *U.S. Oil & Gas Infrastructure Market Size Outlook 2018 – 2024*

U.S. Oil & Gas Infrastructure Market size in 2017 was valued over USD 70 billion and is anticipated to grow over 1% by 2024 driven by ongoing exploitation of nonconventional oil and gas resources including shale.      
https://www.gminsights.com/industry-analysis/us-oil-and-gas-infrastructure-market

*About Global Market Insights*

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

CONTACT: Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://express-journal.com/ Reported by GlobeNewswire 12 minutes ago.

DEAG Deutsche Entertainment Aktiengesellschaft: Effective immediately, MyTicket a 100% subsidiary of DEAG

$
0
0
DGAP-News: DEAG Deutsche Entertainment Aktiengesellschaft / Key word(s): Share Buyback

22.01.2019 / 10:56
The issuer is solely responsible for the content of this announcement.
--------------------

 

*Corporate News*

*Effective immediately, MyTicket a 100% subsidiary of DEAG *

*- *DEAG acquires 24.9% of Axel Springer shares

- From summer 2019 on cooperation with the ticketing software vendor SecuTix

*Berlin, 22 January 2019* - DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, ISIN: DE000A0Z23G6, Ticker: ERMK, which is listed in the Prime Standard of the Frankfurt Stock Exchange, is acquiring 24.9% of the shares in mytic myticket AG ("MyTicket AG") from Axel Springer SE and will thus hold 100% of the company in the future. The transaction is a further step towards further international expansion and the gradual reduction of minority interests with the aim of increasing the earnings per share attributable to DEAG shareholders.

"Many thanks to our partners from Axel Springer SE for working together to establish MyTicket AG in the start-up phase, and I look forward to continuing our close cooperation in the other areas as before. The market shares of MyTicket AG are growing strongly and with myticket.de and myticket.at it has developed into one of the leading electronic ticket platforms. The transaction will enable us to further implement our strategic goals: The acquisition of the shares in MyTicket will enable us to increase earnings per share over the next few years. In addition, we will continue to expand DEAG's ticketing business and intend to expand further internationally. After the introduction phase with millions of tickets sold and hundreds of thousands of satisfied customers, the team can now implement the next phase of the growth course," said *Prof. Peter Schwenkow*, CEO of DEAG Deutsche Entertainment AG.

In addition, MyTicket will cooperate with the Swiss ticket software vendor "SecuTix" starting in summer 2019. SecuTix as SaaS provider and a partner of many prominent organizers and venues offers software solutions for international ticket sales of concerts and show events as well as innovative solutions for culture, festivals, sports, tournaments, exhibitions and fairs. Furthermore, the latest technologies, such as Blockchain and "Dynamic Pricing", are used in order to be able to act in a customer-oriented manner and prevent a secondary market from forming.

In the areas of service and product quality as well as customer orientation and user friendliness, major improvements are expected for MyTicket. This will benefit both end customers and organisers who rely on MyTicket as an efficient sales partner.

In addition to improvements at the product and service level, this adjustment will also lead to optimised cost structures and should contribute to increasing profitability in the future.

"Both the repurchase of all shares and the upcoming ticketing software exchange are decisive steps for MyTicket in 2019 in strengthening the company for future tasks and challenges. Furthermore, this will enable us to market the events of the DEAG family and new, innovative formats in direct communication with our customers in an even more targeted manner," commented *Moritz Schwenkow*, CEO of mytic MyTicket AG.

*Frédéric Longatte*, CEO of SecuTix SA, explains: "We are very proud to be able to contribute to the continued success of MyTicket with SecuTix 360 . SecuTix has extensive experience in all genres that MyTicket offers on its portal. With our ticketing engagement platform, we are the ideal partner for MyTicket to offer promoters and events, be it sports, festivals or culture, a powerful solution for marketing and distribution."

*About DEAG*

DEAG Deutsche Entertainment Aktiengesellschaft (DEAG) is a leading entertainment service company and a provider of Live Entertainment in Europe with subsidiaries in its core markets. DEAG produces and profitably organises a broad range of live entertainment events and concerts. As a Live Entertainment service company with an integrated business model DEAG has extensive expertise in the organisation, marketing and holding of events, as well as in ticket sales via its own ticketing platform 'MyTicket' for its own and third-party content. The highly scalable business model of MyTicket strengthens DEAG on its way to increasing profitability. DEAG promotes around 4,000 concerts and events a year and currently sells more than 5 million tickets, of which a steadily increasing share is sold via its high-turnover ticketing platform MyTicket.

Founded in Berlin in 1978 and listed since 1998, DEAG's core businesses include Rock/Pop, Classics & Jazz, Family Entertainment and Arts+Exhibitions. The Family Entertainment and Arts+Exhibitions divisions in particular are of great importance to the further development of DEAG's own content. With its strong partner network, DEAG is excellently positioned in the market as an internationally active Live Entertainment service company.

DEAG shares (ISIN: DE000A0Z23G6 | WKN: A0Z23G | ERMK) are listed in the Prime Standard of the Frankfurt Stock Exchange, the quality segment of Deutsche Börse.

*IR contact *

cometis AG
Claudius Krause
Phone: +49-611-20585528
email: deag@cometis.de

 
--------------------

22.01.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de --------------------

Language: English
Company: DEAG Deutsche Entertainment Aktiengesellschaft
Potsdamer Straße 58
10785 Berlin
Germany
Phone: +49-30-810 75-0
Fax: +49-30-810 75-519
E-mail: deag@cometis.de
Internet: www.deag.de
ISIN: DE000A0Z23G6, DE000A2NBF25
WKN: A0Z23G, A2NBF2
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange; London
 
End of News DGAP News Service Reported by EQS Group 4 minutes ago.

Michelin : Michelin acquires leading Indonesian tire manufacturer PT Multistrada Arah Sarana TBK

$
0
0
*   Press release*
Clermont-Ferrand - January 22, 2019

*COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN*

* *

*Michelin acquires leading Indonesian tire manufacturer PT Multistrada Arah Sarana TBK, *
*thereby gaining competitive production capacity of more than 180 000 Tons and strengthening its presence in the fast-growing Indonesian market*

* *

 

In line with its strategy, Michelin today announced it has signed an agreement to acquire 80% of PT Multistrada Arah Sarana TBK ("Multistrada"), a tire manufacturer based in Indonesia. With a production capacity of more than 180 thousand Tons (i.e., 11 million Passenger car tires, 9 million Two-wheel tires and 250 thousand Truck tires), Multistrada generated net sales of USD 281 million in 2017. With this transaction, Michelin will strengthen its presence in the highly promising but local-production dominated Indonesian market by acquiring a very competitive local plant with good quality facilities and immediately available production capacity. Leveraging its technical expertise with limited new investment, Michelin will gradually convert production from Tier 3 passenger car tires to Tier 2 Michelin Group brands, thereby allowing more Tier 1 production at other Asian plants and supporting growth of demand of Tier 2 volumes in Europe, North America and Asia.

In addition, through the transaction Michelin will acquire a 20% stake in the retailer PT Penta Artha Impressi ("Penta") in partnership with Indomobil and private investors, which will boost the marketing and sales of Michelin Group brands in Indonesia allowing Michelin to secure significant access to a major market and be well placed to benefit from the market's future growth and expansion.

Jean-Dominique Senard, Chief Executive Officer of the Michelin Group, said: "The acquisition of Multistrada represents an excellent opportunity for Michelin to expand its operations in Indonesia, the most populous country in Southeast Asia, and immediately gain competitive, good-quality production capacity without having to create any new manufacturing facilities."

Pieter Tanuri, Chief Executive Officer of Multistrada, said: "we are very proud of what we achieved with Multistrada and we are confident Michelin is the ideal partner to take Multistrada forward into a new era of growth and success for the benefit of all stakeholders and employees."

Potential synergies in manufacturing, sales and purchasing are expected to represent up to USD 70 million per year within 3 years of the acquisition. Multistrada, including the 20% stake in the retailer PT Penta and 50 hectares of available land, has been valued at USD 700 million enterprise value, representing 6.3 times EBITDA for the 12 months ended  September 30^th, 2018, after expected synergies.

Upon closing, Michelin will pay USD 439 million for 80% of the Multistrada shares subject to certain closing adjustments. As Multistrada is a publicly listed company, and pursuant to Indonesian regulations, Michelin will subsequently launch a public offer for the remaining outstanding shares, at the same price per share as that offered to the 80% shareholder group. The acquisition will be funded from internal financial resources and is not expected to have an impact on Michelin's ratings.     
                                                                                                                                                                                                 

                                                                                                                                                                           

* *

*Investor Relations*

* *

Édouard de Peufeilhoux
+33 (0) 4 73 32 74 47
+33 (0) 6 89 71 93 73 (mobile)
edouard.de-peufeilhoux@michelin.com

 

Matthieu Dewavrin
+33 (0) 4 73 32 18 02
+33 (0) 6 71 14 17 05 (mobile)
matthieu.dewavrin@michelin.com

 

Humbert de Feydeau
+33 (0) 4 73 32 68 39
+33 (0) 6 82 22 39 78 (mobile)
humbert.de-feydeau@michelin.com

  * *

*Media Relations*

 

Corinne Meutey
  +33 (0) 1 78 76 45 27
  +33 (0) 6 08 00 13 85 (mobile)
corinne.meutey@michelin.com

* *

* *

*Individual Shareholders*

* *

Isabelle Maizaud-Aucouturier
  +33 (0) 4 73 98 59 27
isabelle.maizaud-aucouturier@michelin.com

 

Clémence Rodriguez
  +33 (0) 4 73 98 59 25
clemence.daturi-rodriguez@michelin.com

 

*Attachment*

· 20190122_PR_Michelin acquires Multistrada.pdf Reported by GlobeNewswire 1 hour ago.

McPhy Energy: FY 2018 revenue of €8 million

$
0
0
* Press release*

*McPhy: FY 2018 revenue of €8 million *

· Confirmation of a 21% decline in FY 2018 revenue compared to FY 2017 due to delays affecting several orders
· FY 2018 operating performance expected to show the impact of this top-line contraction
· High rate of growth maintained in Europe, with revenue up 23% compared to FY 2017
· Confirmation of a sustained commercial activity and a "qualified commercial pipeline"^[1] estimated at over €80 million
· Further business expansion expected in 2019

*La Motte-Fanjas, January 22, 2019 at 5:45pm - McPhy (Euronext Paris Compartment C: MCPHY, FR0011742329) *a specialist in hydrogen production and distribution equipment, is today announcing its revenue for the financial year ended December 31, 2018.

(in millions of euros) *2018* *2017* *Change*
*First half* *3.5* *5.5* -36%
*Second half* *4.5* *4.6* -2%
*Total revenue* *8.0* *10.1* *-21%*

 *We expect our revenue to return to growth in 2019 [.] supported by the expansion in our qualified pipeline [.] and operational implementation of our partnership with EDF, under which we are making joint submissions for heavy mobility competitive tenders"* Pascal Mauberger, Chairman and Chief Executive Officer of McPhy, commented: "The contraction in our 2018 revenue mainly reflects the delays in the concretization of several orders and an extension to the length of certain existing projects by McPhy's customers, despite highly buoyant conditions in the clean hydrogen market worldwide. These orders should materialize on the medium term.

For example, the permit for the second hydrogen station in Lyon awarded at the beginning of 2018 entered into force only in December.

We anticipate revenue growth in 2019 supported by a qualified pipeline of over €80 million and operational implementation of our partnership with EDF, under which we are making joint submissions for heavy mobility competitive tenders such as bus refueling stations with a capacity of several hundred kg per day; and such as platforms fueling hydrogen trains and river ferries with a capacity of over 1 tonne per day are among the projects being tendered for. We are confident in McPhy's ability to seize and convert market opportunities owing to its renowned expertise and its cutting-edge technologies geared to meeting the colossal market needs linked to the imperative transition towards a lower carbon economy."

*21% contraction in McPhy's FY 2018 revenue*

McPhy's revenue fell 21% to €8 million in the financial year to December 31, 2018. This anticipated and announced contraction mainly reflects the delays in the concretization of several orders and an extension to the length of certain existing projects by McPhy's customers. Revenue in Europe continued to deliver a high growth, rising 23% in FY 2018.

Revenue in Asia was held back by an end to recognition of revenue related to the €6.4 million contract to deliver the 4 MW Power-to-Gas equipment in Hebei (China). Excluding the impact of this contract, revenue growth would have been 9% in FY 2018.

McPhy held €14.9 million in cash at December 31, 2018.

*Key milestones achieved by McPhy in clean hydrogen market that remains as buoyant as ever*

The expected ramp-up in the hydrogen market predicted in the Hydrogen Council's "Scaling Up" report^[2] continued in 2018. The French government also undertook to support the development of a carbon-free hydrogen sector as part of the energy transition. In 2019, it is expected to set aside a budget of €100 million for the roll-out of carbon-free hydrogen in the industry, mobility and energy sectors across France.

Amid buoyant market conditions, McPhy reaffirmed its leadership credentials with major industry players and forged key partnerships.

In April, it launched a whole new generation of electrolyzers under its technology partnership with De Nora. This provides a genuine technological breakthrough substantially strengthening its competitive advantage.

McPhy has also expanded its hydrogen mobility offering. In May 2018, McPhy won a contract with the Lens-Béthune urban area for a 200kg/day 350-bar refueling station. This station, which is due to enter into service in the first half of 2019, ultimately will power 10 hydrogen buses. McPhy also developed a line of dedicated refueling stations for 700-bar vehicles. These successfully passed the tests held jointly with Toyota, the leader in carbon-free mobility, paving the way for the architecture for the first series to be finalized in late 2018. An order has now been received for the first 200kg/day 700-bar refueling station close to Berlin in Germany, scheduled for delivery in late 2019.

McPhy also signed in June 2018 an industrial and commercial partnership with EDF, the world leader in low-carbon energies to develop carbon-free hydrogen in France and around the world. With the additional financial resources and the partnership of the EDF group, McPhy will be able to accelerate the pace of its growth, strengthen its business development, and conquer new markets.

*Further business expansion expected in 2019*

The delayed orders, which impacted McPhy's FY 2018 revenue and all its results, are expected to materialize on the medium term. Its "qualified commercial pipeline" currently stands at over €80 million, providing further evidence of its sustained commercial activity.

McPhy has received an order for a next-generation 40kg/day 30-bar electrolyzer, which will be delivered this year. It is intended for a refueling station to be built by ATAWEY^[3] and located in Chambéry as part of the Zero Emission Valley project^[4] in the Auvergne-Rhône-Alpes region. Under the project, 20 stations are due to be installed across the region, including 15 with electrolyzers^[5].

In addition, McPhy has recently received an order for 11 electrolyzers from the PIEL line, which are due to be delivered during 2019. These electrolyzers will be used to inflate balloons for weather probes. This is the largest order ever placed for McPhy's PIEL line of products.

Lastly, the industrial and commercial partnership agreed with EDF in 2018, to develop carbon-free hydrogen in France and around the world, is now fully operational. McPhy and EDF will now make joint submissions to calls for tenders for bus refueling stations with a capacity of several hundred kg/d based on electrolyzers and for platforms to power hydrogen trains and river ferries with a capacity of over 1 tonne per day.

As a result, McPhy expects its revenue to return to growth in 2019.

*Next press release:*

FY 2018 results on Tuesday, March 12, 2019 (after the market close)

                                                                                                                                                                           

*About McPhy*

In the framework of the energy transition, and as a leading supplier of hydrogen production, storage and distribution equipment, McPhy contributes to the deployment of clean hydrogen throughout the world.

Thanks to its wide range of products and services dedicated to the hydrogen energy, zero emission mobility and industrial hydrogen markets, McPhy provides turnkey solutions to its clients. These solutions are tailored to our client applications: renewable energy surplus storage and valorization, fuel cell car refueling, raw material for industrial sites.

As a designer, manufacturer and integrator of hydrogen equipment since 2008, McPhy has three development, engineering and production units based in Europe (France, Italy, Germany).

The company's international subsidiaries ensure a global sales coverage of McPhy's innovative hydrogen solutions.

McPhy is listed on NYSE Euronext Paris (Segment C, ISIN code: FR0011742329; ticker: MCPHY).
*Media relations*

*NewCap*
Nicolas Merigeau
T. +33 (0)1 44 71 94 98
mcphy@newcap.eu

 

*Investors Relations*

*NewCap*
Julie Coulot | Emmanuel Huynh
T. +33 (0)1 44 71 20 40
mcphy@newcap.eu *Follow us on*

 

@McPhyEnergy   

* *
^[1] Projects on which McPhy rates its chances of success and a go-ahead at over 50%  

^[2]http://hydrogencouncil.com/hydrogen-scaling-up/

^[3]http://www.atawey.com

^[4]  https://www.auvergnerhonealpes.fr/uploads/Presse/91/203_486_CP-12-20-Zero-Emission-Valley-reconnu-au-niveau-europeen.pdf

^[5]  https://www.auvergnerhonealpes.fr/uploads/Presse/91/203_486_CP-12-20-Zero-Emission-Valley-reconnu-au-niveau-europeen.pdf

*Attachment*

· McPhy_FY 2018 sales.pdf Reported by GlobeNewswire 1 hour ago.

French protests weigh on Carrefour fourth-quarter hypermarket sales

$
0
0
Carrefour , Europe's largest retailer, said on Tuesday that sales growth slowed in the fourth quarter, as 10 weeks of anti-government protests hurt hypermarket sales in its core French market. Reported by Reuters 45 minutes ago.

Top U.S. diplomat for Europe resigns from State Department: sources

$
0
0
The top U.S. diplomat for European affairs, Wess Mitchell, has resigned, according to his resignation letter obtained by Reuters on Tuesday. Reported by Reuters 47 minutes ago.

Orgenesis Subsidiary Atvio Biotech to Present at Phacilitate Leaders World 2019 Conference

$
0
0
Presentation entitled "Bringing cell therapy to the point of care, automation, analytics and everything between"

GERMANTOWN, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer, manufacturer and service provider of advanced cell therapies, today announced that Dr. Ohad Karnieli, Ph.D., MBA, from Atvio Biotech Ltd. management, which is wholly-owned by Orgenesis’ Masthercell Global subsidiary, will be presenting at the Phacilitate Leaders World 2019 Conference.  The presentation will be held on Thursday, January 24, 2019 at 3:50 p.m. Eastern Standard Time at the Hyatt Regency Miami. The presentation is entitled, "Bringing cell therapy to the point of care, automation, analytics and everything between.”  The Company will also host a booth (#804) throughout the duration of the event.Phacilitate Leaders World 2019 is the world’s largest advanced therapies partnering event.  The event is co-located with the World Stem Cell Summit, incorporating the entire advanced therapies ecosystem.  Phacilitate Leaders World 2019 and the World Stem Cell Summit provide a platform to build new partnerships, empower future leaders and evolve advanced therapies.  The event is expected to attract 2,000 attendees, 150 exhibitors and 300 speakers.

*About Orgenesis*
Orgenesis is a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and support services.  Through its Israeli subsidiary, Orgenesis Ltd., Orgenesis is developing technology designed to successfully reprogram human liver cells into glucose-responsive, fully functional, Insulin Producing Cells (IPCs).  Orgenesis believes that converting the diabetic patient's own tissue into insulin-producing cells has the potential to overcome the significant issues of donor shortage, cost and exposure to chronic immunosuppressive therapy associated with islet cell transplantation.  Through its Masthercell Global subsidiary, a global contract development and manufacturing organization (CDMO), Orgenesis is able to deliver optimized process industrialization capacities to cell therapy organizations and speed up the arrival of their therapies onto the market.  From technology selection to business modeling, GMP manufacturing, process development, and quality management, Masthercell’s teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.  Masthercell operates in a validated and flexible facility located in the strategic center of Europe within the Walloon healthcare cluster, Biowin.  This integrated approach supports the Company's business philosophy of bringing to market significant life-improving medical treatments.  For more information, visit www.orgenesis.com.

*Notice Regarding Forward-Looking Statements
*This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended.  These forward-looking statements involve substantial uncertainties and risks and are based upon our current expectations, estimates and projections and reflect our beliefs and assumptions based upon information available to us at the date of this release.  We caution readers that forward-looking statements are predictions based on our current expectations about future events.  These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict.  Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including, but not limited to, the success of our reorganized CDMO operations, the success of our partnership with Great Point Partners, our ability to achieve and maintain overall profitability, the sufficiency of working capital to realize our business plans, the development of our transdifferentiation technology as therapeutic treatment for diabetes which could, if successful, be a cure for Type 1 Diabetes; our technology not functioning as expected; our ability to retain key employees; our ability to satisfy the rigorous regulatory requirements for new procedures; our competitors developing better or cheaper alternatives to our products and the risks and uncertainties discussed under the heading "RISK FACTORS" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended November 30, 2017, and in our other filings with the Securities and Exchange Commission.  We undertake no obligation to revise or update any forward-looking statement for any reason.

*Contact for Orgenesis:*
David Waldman
Crescendo Communications, LLC
Tel: 212-671-1021
Orgs@crescendo-ir.com Reported by GlobeNewswire 45 minutes ago.

UEFA figures detail the meteoric rise of Leicester City following Champions League campaign

$
0
0
UEFA figures detail the meteoric rise of Leicester City following Champions League campaign City had the second fastest growing revenue in Europe in 2017 Reported by Leicester Mercury 21 minutes ago.

Top US diplomat for Europe resigns

$
0
0
WASHINGTON (AP) — The top U.S. diplomat for Europe is resigning after only 14 months on the job in a blow to Trump administration efforts to maintain trans-Atlantic unity.The State Department says Wess Mitchell will leave his post... Reported by New Zealand Herald 51 minutes ago.

Europe Wants to Start Mining the Surface of the Moon by 2025

$
0
0
Europe Wants to Start Mining the Surface of the Moon by 2025 It looks like Europe is planning their own moon mission. The European Space Agency (ESA) revealed plans to study and prepare for a mission to go to the Moon with the aim of […]

The post Europe Wants to Start Mining the Surface of the Moon by 2025 appeared first on Geek.com. Reported by geek.com 41 minutes ago.

Coinbase Adds Cross-Border Wire Transfers for High-Volume Customers in Europe, Asia

$
0
0
Coinbase Adds Cross-Border Wire Transfers for High-Volume Customers in Europe, Asia Coinbase adds international wire transfers for high-volume Coinbase Pro and Prime users in Europe and Asia Reported by The Cointelegraph 37 minutes ago.

Honor Watch Magic officially announced for Europe

$
0
0
Reported by TechRadar 41 minutes ago.

2019 ISPE Europe Annual Conference Keynote Speakers Announced

$
0
0
Keynote addresses will showcase global pharmaceutical industry leaders offering compelling and enlightening presentations on industry-critical technical developments.

BETHESDA, Md. (PRWEB) January 22, 2019

The International Society for Pharmaceutical Engineering (ISPE) announced its keynote speakers for their 2019 Europe Annual Conference. Taking place in Dublin, Ireland, 1–4 April 2019, keynote addresses will showcase global pharmaceutical industry leaders offering compelling and enlightening presentations on industry-critical technical developments.

Keynote Speakers:
Jim Breen, Vice President – Lead Biologics Expansion, Janssen Pharmaceuticals, ISPE Board Chair
Jim will highlight Johnson & Johnson’s approach to organise innovation from an engineering and technology perspective. He will highlight how J&J has improved agility of the production within the context of a rapidly changing portfolio with shorter life times.

Rick Friedman, Deputy Director, Science & Regulatory Policy, Office of Manufacturing Quality, FDA
Rick will deliver feedback on what the FDA’s position is alongside all the new technical innovations facing the pharmaceutical industry. He will shed light on what FDAs expectations are on how to be involved and how to control manufacturing and product quality in the context of big data.

Joydeep Ganguly, Vice President – Engineering, Facilities & Operations, Gilead Sciences
Joydeep will provide his view on the meaning of excellence in project management in the world of digitisation. He will offer insight into a vision of what pharmaceutical facilities will look like in the future, as well as what the main processes in operations currently are and will become.

Brendan O'Callaghan, Head Biologics, Sanofi
Brendan and his team are making headway in personalised medicine, which brings several new challenges for operations management in the pharmaceutical industry. His presentation will focus on the development of next generation biologics and will also touch on the manufacturing costs of the future and how this relates to the cost of goods sold (COGS) today.

Thomas Wozniewski, Global Head of Operations, Takeda/Shire
As the global head of operations for all technologies and factories from the new Takeda/Shire operations, Thomas will give his perspective on global relevant success factors for pharmaceutical manufacturing and quality. He will talk about the political boundaries of the intensifying trade barriers and new political discussion about sustainability of operations in the context of global warming.

The 2019 ISPE Europe Annual Conference delivers a broad spectrum of technical education for multiple levels of expertise across four tracks and more than 60 education sessions. In addition, the event features an Executive Forum, four plant tours, and expo hall.

To learn more about this event and to register, visit http://www.ISPE.org/Conferences/2019-Europe-Annual-Conference.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: mrobertson@ispe.org
http://www.ISPE.org Reported by PRWeb 37 minutes ago.

Maisons du Monde: Full-year 2018 trading update

$
0
0
*PRESS RELEASE*

*MAISONS DU MONDE: FULL-YEAR 2018 TRADING UPDATE*

*Full-year 2018 sales and results*^[1]* in line with targets, demonstrating*

*Maisons du Monde's resilience in a fourth quarter marked by*

*exceptional trading conditions in France*

_________________________________________

*Sales up 10% year-on-year, of which +7.4% at constant perimeter*

_________________________________________

*Nantes, 22 January 2019*

Given the context of the "Yellow Vests" movement that marked the fourth quarter of 2018 in France, Maisons du Monde (Euronext Paris: MDM, ISIN Code: FR0013153541) is issuing today an exceptional trading update on its full-year 2018 sales and results ahead of the full publication.

Based on unaudited figures, Maisons du Monde confirms that its sales and results for the year ended 31 December 2018 are in line with the Group's full-year targets, which were adjusted in the third quarter to reflect an anticipated softer trading environment in France.

With year-on-year sales growth of 7.4% at constant perimeter, of which 3% like-for-like, and 10% including Modani, these unaudited figures for full-year 2018 demonstrate the strength of Maisons du Monde's omnichannel and international strategy, with continued momentum in online sales, including in France, and strong commercial dynamics across its European markets.

In the fourth quarter of 2018, Maisons du Monde reported sales growth of 5.6% year-on-year at constant perimeter, of which 2% like-for-like, and 9.3% including Modani. This performance was achieved despite a challenging retail environment in France, which was further impacted by the "Yellow Vests" movement.

Based on its initial review, Maisons du Monde also confirms its EBITDA margin target of above 13% of sales for full-year 2018.

In line with its updated targets, Maisons du Monde recorded 22 net openings in 2018, of which its first store in the United States under its banner, in addition to 3 net openings by Modani.

Maisons du Monde will release its fourth-quarter and full-year 2018 results on 12 March 2019.

*****

*About Maisons du Monde*

Maisons du Monde is a creator of inspirational lifestyle universes in the homeware industry, offering distinctive and affordable decoration and furniture collections that showcase multiple styles. The Group develops its business through an integrated and complementary omnichannel approach, leveraging its international network of stores, websites and catalogues. The Group was founded in France in 1996 and has profitably expanded across Europe since 2003. The Group posted sales of €1,011 million and EBITDA of €139 million for the year ended 31 December 2017. In 2017, the Group operated 313 stores in seven countries including France, Italy, Spain, Belgium, Germany, Switzerland, and Luxembourg, and derived over 38% of its sales from outside France. The Group has also built a successful complementary and comprehensive online shopping website, sales from which grew 35% per year on average between 2010 and 2017. The website is available in eleven countries: the seven countries where the Group operates stores plus Austria, the Netherlands, Portugal and the United Kingdom. In 2017, online sales represented 21% of the Group's sales.

corporate.maisonsdumonde.com

*****

*Contacts*

*Investor Relations* *Press Relations*
Laurent Sfaxi - +33 2 51 71 52 07 Clémentine Prat - +33 2 51 79 54 08
lsfaxi@maisonsdumonde.com cprat@maisonsdumonde.com
^[1] Unaudited figures.

*Attachment*

· PDF Version.pdf Reported by GlobeNewswire 24 minutes ago.

Top U.S. diplomat for Europe resigns, cites personal, professional reasons

$
0
0
The top U.S. diplomat for European affairs, Wess Mitchell, has resigned, according to his resignation letter obtained by Reuters on Tuesday. Reported by Reuters 26 minutes ago.

IMMOFINANZ announces the successful placement of a EUR 500 million benchmark bond and received investment grade rating from S&P

$
0
0
DGAP-News: IMMOFINANZ AG / Key word(s): Real Estate/Bond

22.01.2019 / 18:29
The issuer is solely responsible for the content of this announcement.
--------------------
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, OR INTO OTHER COUNTRIES IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT MAY BE UNLAWFUL.
 
 
IMMOFINANZ announces the successful placement of a EUR 500 million benchmark bond and received investment grade rating from S&P
 
 

· Coupon of 2.625%, Notes due 2023
· S&P Global Rating assigned 'BBB-' long-term issuer rating to IMMOFINANZ
· First ever rated benchmark bond by an Austrian real-estate company

 
IMMOFINANZ AG ("IMMOFINANZ") successfully placed EUR 500 million fixed rate senior unsecured notes (the "Notes") with a 4-year maturity and a 2.625% fixed coupon on 21 January 2019. The net proceeds of the issue of the Notes will be used for the refinancing of existing debt and general corporate purposes.
 
Today, S&P Global Rating has assigned a 'BBB-' long-term issuer credit rating to IMMOFINANZ and a 'BBB-' issue rating to the Notes.
 
The reasons cited by S&P Global Rating for its rating decision include, among others, IMMOFINANZ' market position as one of the largest commercial property owners in CEE region, the stable occupancy levels and the stable demand trends in the company's operating environment.
 
"This transaction represents an important milestone for IMMOFINANZ in further diversifying the funding sources with an investment grade rated unsecured instrument, while the refinancing of existing debt will secure currently low interest rates and increase the hedging quota", comments Stefan Schönauer, CFO of IMMOFINANZ. "The investment grade rating underlines the success of our consistent strategy implementation, which has resulted in a very solid financial profile and a sustainable improvement in profitability. Additionally, the transaction also constitutes the first ever rated benchmark bond by an Austrian real-estate company."
 
The Notes have a denomination of EUR 100,000 each and will be listed at the regulated market of the Luxembourg Stock Exchange. An application will be made to introduce the Notes for trading on the Third Market (MTF) of the Vienna Stock Exchange.
 
Deutsche Bank, J.P. Morgan, Société Generale and UniCredit acted as Joint Bookrunners and Joint Lead Managers.
 
As a consequence of the newly achieved investment grade rating, IMMOFINANZ' outstanding convertible bonds 2024 will see a step-down in coupon by 0.5% to 1.5% p.a. already applicable for the next interest period.
 
*On IMMOFINANZ*
IMMOFINANZ is a commercial real estate group whose activities are focused on the retail and office segments of seven core markets in Europe: Austria, Germany, Czech Republic, Slovakia, Hungary, Romania and Poland. The core business covers the management and development of properties, whereby the STOP SHOP (retail), VIVO! (retail) and myhive (office) brands represent strong focal points that stand for quality and service. The real estate portfolio has a value of approx. EUR 4.3 billion and covers more than 220 properties. IMMOFINANZ is listed on the stock exchanges in Vienna (leading ATX index) and Warsaw. Further information under: http://www.immofinanz.com
 
 
*Disclaimer*
The information contained in this announcement is for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. This announcement does not contain or constitute or form part of, and should not be construed as, an offer or invitation to sell, or the solicitation of an offer to buy or subscribe for, any securities.
The distribution of this announcement and the offer and sale of the securities referred to herein may be restricted by law in certain jurisdictions and persons reading this announcement should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented EU Directive 2003/71/EC (together with any amendments and applicable implementing measures in any Member State, the "Prospectus Directive") is addressed solely to qualified investors (within the meaning of the Prospectus Directive) in that Member State. This announcement does not constitute a recommendation concerning the private placement of securities described in this announcement (the "Placement"). Investors should consult a professional advisor as to the suitability of the Placement for the person concerned.
This communication is addressed only to and directed only at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). Any investment activity to which this communication relates will only be available to and will only be engaged with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
This communication is not for public release, publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia). This communication is not and does not constitute or form a part of any offer of, or solicitation to purchase or subscribe for, any securities in the United States. Any such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). Any such securities may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the Securities Act), except pursuant to an exemption from the registration requirements of the Securities Act. No public offering of securities will be made in the United States of America.
MiFID II target market: eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared. No sales to EEA retail.
 
 
*For additional information contact:*
Bettina Schragl
Head of Corporate Communications and Investor Relations
T +43 (0)1 88 090 2290
M +43 (0)699 1685 7290
communications@immofinanz.com
investor@immofinanz.com
  --------------------

22.01.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de --------------------

Language: English
Company: IMMOFINANZ AG
Wienerbergstraße 11
1100 Vienna
Austria
Phone: +43 (0) 1 88090 - 2290
Fax: +43 (0) 1 88090 - 8290
E-mail: investor@immofinanz.com
Internet: http://www.immofinanz.com
ISIN: AT0000A21KS2
WKN: A2JN9W
Listed: Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Warschau, Vienna Stock Exchange (Official Market)
 
End of News DGAP News Service Reported by EQS Group 11 minutes ago.

Regeneus appoints new CEO to accelerate growth into international markets

$
0
0
Regeneus Ltd (ASX:RGS) has appointed experienced pharmaceutical industry executive Leo Lee as chief executive officer, effective immediately. Lee has extensive networks in the industry and speaks Japanese and Chinese, which will provide a real advantage in the development and management of business in Japan and other parts of the Asia Pacific region. READ: Regeneus close to finalising first clinical partnership for its lead cell therapy in Japan Regeneus continues to focus on becoming a global regenerative medicine company developing therapeutics for osteoarthritis, neuropathic pain and dermatology. Lee succeeds outgoing CEO John Martin who has provided 10 years of service to Regeneus and will continue to serve on the board as a non-executive director. The new CEO said: “I am thrilled to be joining Regeneus at such an exciting time. “I see tremendous opportunities for accelerating patients’ access to our therapies around the world and delivering significant shareholder value. “Execution will be our priority as we explore options around the world for Progenza and Sygenus.” READ: Regeneus granted patent in China related to biomarkers for stem cell therapy In a statement the company said: “The board would like to thank John Martin for his 10 years’ service, his vision and extensive efforts in the development of Progenza and Sygenus into important assets for Regeneus, which will transform the quality of life of patients. “John’s dedication and passion has been instrumental in the creation of Regeneus. “The board would also like to acknowledge the quality of the management team that John has built and thank them for their service and accomplishments.” Lee joined the board as an independent non-executive director in December 2017. Since that time, he has gained valuable insight into the company’s business and strategy and has developed important relationships with the board and senior management. Lee will lead Regeneus’ ongoing efforts to secure its first major clinical licence of Progenza in Japan. Even though the Regeneus’ partnership discussions with potential licensees have taken longer than anticipated, the company remains confident of a successful commercial outcome. Expansion into key global markets Lee has extensive experience in leading pharmaceutical companies in Japan having been the former president of Japan for both Merck and Allergan. He brings a unique set of skills and experience to the company as it seeks to partner its stem cell technologies in the key markets of Japan, USA and Europe and emerging markets of China and South Korea. Reported by Proactive Investors 4 hours ago.

Android stomps across Europe with 73.3% of key market smartphone sales

$
0
0
Android stomps across Europe with 73.3% of key market smartphone sales Reported by Eurodroid 4 hours ago.

Trump has another potential trade war looming

$
0
0
Sharemarkets shivered when it appeared there had been a setback in US-China trade talks. How are they going to respond if the US decides to declare (a trade) war on Europe? Reported by Brisbane Times 3 hours ago.
Viewing all 65275 articles
Browse latest View live




Latest Images